Found 166 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530482
(WO2022076764, Example 11)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C24H16ClF4N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(13-2-6-15(25)7-3-13)30-24(32)31-22(33)14-4-8-16(9-5-14)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530483
(WO2022076764, Example 12)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(Cl)c1 Show InChI InChI=1S/C24H16ClF4N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(14-3-2-4-15(25)9-14)30-24(32)31-22(33)13-5-7-16(8-6-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530486
(WO2022076764, Example 15)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(C)cc1 Show InChI InChI=1S/C25H19F4N3O3/c1-14-3-5-15(6-4-14)21-13-32(22-19(26)11-18(34-2)12-20(22)27)25(30-21)31-23(33)16-7-9-17(10-8-16)35-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530488
(WO2022076764, Example 17)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(c1)C#N Show InChI InChI=1S/C25H16F4N4O3/c1-35-18-10-19(26)22(20(27)11-18)33-13-21(16-4-2-3-14(9-16)12-30)31-25(33)32-23(34)15-5-7-17(8-6-15)36-24(28)29/h2-11,13,24H,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530496
(WO2022076764, Example 25)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1F Show InChI InChI=1S/C24H16F5N3O3/c1-34-15-10-18(26)21(19(27)11-15)32-12-20(16-4-2-3-5-17(16)25)30-24(32)31-22(33)13-6-8-14(9-7-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530497
(WO2022076764, Example 26)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2cc(Cl)ccc2o1 Show InChI InChI=1S/C25H17ClF2N4O4/c1-34-17-9-5-16(6-10-17)32-13-20(23-29-19-12-15(26)4-11-21(19)36-23)30-25(32)31-22(33)14-2-7-18(8-3-14)35-24(27)28/h2-13,24H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 72 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530499
(WO2022076764, Example 28)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccn1 Show InChI InChI=1S/C23H18F2N4O3/c1-31-17-11-7-16(8-12-17)29-14-20(19-4-2-3-13-26-19)27-23(29)28-21(30)15-5-9-18(10-6-15)32-22(24)25/h2-14,22H,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530507
(WO2022076764, Example 36)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)c(F)c1 Show InChI InChI=1S/C24H15F6N3O3/c1-35-15-9-18(27)21(19(28)10-15)33-11-20(13-4-7-16(25)17(26)8-13)31-24(33)32-22(34)12-2-5-14(6-3-12)36-23(29)30/h2-11,23H,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530513
(WO2022076764, Example 42)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(F)(F)C(F)(F)F Show InChI InChI=1S/C20H12F9N3O3/c1-34-11-6-12(21)15(13(22)7-11)32-8-14(19(25,26)20(27,28)29)30-18(32)31-16(33)9-2-4-10(5-3-9)35-17(23)24/h2-8,17H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530516
(WO2022076764, Example 45)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNCC1 Show InChI InChI=1S/C23H23F2N5O4/c1-33-17-8-4-16(5-9-17)30-14-19(21(32)29-12-10-26-11-13-29)27-23(30)28-20(31)15-2-6-18(7-3-15)34-22(24)25/h2-9,14,22,26H,10-13H2,1H3,(H,27,28,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 710 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530521
(WO2022076764, Example 50)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC[C@H]1CO Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-9-17(25)20(18(26)10-16)32-11-19(22(35)31-8-2-3-14(31)12-33)29-24(32)30-21(34)13-4-6-15(7-5-13)37-23(27)28/h4-7,9-11,14,23,33H,2-3,8,12H2,1H3,(H,29,30,34)/t14-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530522
(WO2022076764, Example 51)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCCC(O)C1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-9-17(25)20(18(26)10-16)32-12-19(22(35)31-8-2-3-14(33)11-31)29-24(32)30-21(34)13-4-6-15(7-5-13)37-23(27)28/h4-7,9-10,12,14,23,33H,2-3,8,11H2,1H3,(H,29,30,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530523
(WO2022076764, Example 52)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(O)CC1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-10-17(25)20(18(26)11-16)32-12-19(22(35)31-8-6-14(33)7-9-31)29-24(32)30-21(34)13-2-4-15(5-3-13)37-23(27)28/h2-5,10-12,14,23,33H,6-9H2,1H3,(H,29,30,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 63 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530526
(WO2022076764, Example 55)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCN(C)CC1 Show InChI InChI=1S/C24H23F4N5O4/c1-31-7-9-32(10-8-31)22(35)19-13-33(20-17(25)11-16(36-2)12-18(20)26)24(29-19)30-21(34)14-3-5-15(6-4-14)37-23(27)28/h3-6,11-13,23H,7-10H2,1-2H3,(H,29,30,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 280 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530530
(WO2022076764, Example 59)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(CO)C1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-8-17(25)20(18(26)9-16)32-11-19(22(35)31-7-6-13(10-31)12-33)29-24(32)30-21(34)14-2-4-15(5-3-14)37-23(27)28/h2-5,8-9,11,13,23,33H,6-7,10,12H2,1H3,(H,29,30,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 82 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530538
(A-{4-[1-(3-Carbamoylpropanoyl)piperidin-4-yl]-1-(2...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCN(CC1)C(=O)CCC(N)=O Show InChI InChI=1S/C27H27F4N5O5/c1-40-18-12-19(28)24(20(29)13-18)36-14-21(15-8-10-35(11-9-15)23(38)7-6-22(32)37)33-27(36)34-25(39)16-2-4-17(5-3-16)41-26(30)31/h2-5,12-15,26H,6-11H2,1H3,(H2,32,37)(H,33,34,39) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 54 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530475
(WO2022076764, Example 4)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)cc1 Show InChI InChI=1S/C24H16F5N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(13-2-6-15(25)7-3-13)30-24(32)31-22(33)14-4-8-16(9-5-14)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530475
(WO2022076764, Example 4)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)cc1 Show InChI InChI=1S/C24H16F5N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(13-2-6-15(25)7-3-13)30-24(32)31-22(33)14-4-8-16(9-5-14)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530477
(WO2022076764, Example 6)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(cc1)C(F)(F)F Show InChI InChI=1S/C25H16F7N3O3/c1-37-17-10-18(26)21(19(27)11-17)35-12-20(13-2-6-15(7-3-13)25(30,31)32)33-24(35)34-22(36)14-4-8-16(9-5-14)38-23(28)29/h2-12,23H,1H3,(H,33,34,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 76 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530478
(WO2022076764, Example 7)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H17F6N3O4/c1-36-17-10-18(26)21(19(27)11-17)34-12-20(13-2-6-15(7-3-13)37-23(28)29)32-25(34)33-22(35)14-4-8-16(9-5-14)38-24(30)31/h2-12,23-24H,1H3,(H,32,33,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530479
(WO2022076764, Example 8)Show SMILES COc1cc(F)c(c(F)c1)-n1c(C)c(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C25H19F4N3O3/c1-14-21(15-6-4-3-5-7-15)30-25(32(14)22-19(26)12-18(34-2)13-20(22)27)31-23(33)16-8-10-17(11-9-16)35-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530480
(WO2022076764, Example 9)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2ccccc2c1 Show InChI InChI=1S/C28H19F4N3O3/c1-37-21-13-22(29)25(23(30)14-21)35-15-24(19-7-6-16-4-2-3-5-18(16)12-19)33-28(35)34-26(36)17-8-10-20(11-9-17)38-27(31)32/h2-15,27H,1H3,(H,33,34,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530482
(WO2022076764, Example 11)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C24H16ClF4N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(13-2-6-15(25)7-3-13)30-24(32)31-22(33)14-4-8-16(9-5-14)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530483
(WO2022076764, Example 12)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(Cl)c1 Show InChI InChI=1S/C24H16ClF4N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(14-3-2-4-15(25)9-14)30-24(32)31-22(33)13-5-7-16(8-6-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 450 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530485
(WO2022076764, Example 14)Show SMILES COc1ccc(cc1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H19F4N3O4/c1-34-16-7-3-14(4-8-16)21-13-32(22-19(26)11-18(35-2)12-20(22)27)25(30-21)31-23(33)15-5-9-17(10-6-15)36-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530493
(WO2022076764, Example 22)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2sccc2c1 Show InChI InChI=1S/C26H19F2N3O3S/c1-33-20-9-5-19(6-10-20)31-15-22(17-4-11-23-18(14-17)12-13-35-23)29-26(31)30-24(32)16-2-7-21(8-3-16)34-25(27)28/h2-15,25H,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530495
(WO2022076764, Example 24)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nccs1 Show InChI InChI=1S/C21H16F2N4O3S/c1-29-15-8-4-14(5-9-15)27-12-17(19-24-10-11-31-19)25-21(27)26-18(28)13-2-6-16(7-3-13)30-20(22)23/h2-12,20H,1H3,(H,25,26,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530496
(WO2022076764, Example 25)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1F Show InChI InChI=1S/C24H16F5N3O3/c1-34-15-10-18(26)21(19(27)11-15)32-12-20(16-4-2-3-5-17(16)25)30-24(32)31-22(33)13-6-8-14(9-7-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 47 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530505
(WO2022076764, Example 34)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccnc(Cl)c1 Show InChI InChI=1S/C23H15ClF4N4O3/c1-34-15-9-16(25)20(17(26)10-15)32-11-18(13-6-7-29-19(24)8-13)30-23(32)31-21(33)12-2-4-14(5-3-12)35-22(27)28/h2-11,22H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530506
(WO2022076764, Example 35)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC(C)C)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C22H21F4N3O3/c1-12(2)8-14-11-29(19-17(23)9-16(31-3)10-18(19)24)22(27-14)28-20(30)13-4-6-15(7-5-13)32-21(25)26/h4-7,9-12,21H,8H2,1-3H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530509
(WO2022076764, Example 38)Show SMILES CCOC(=O)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C21H17F4N3O5/c1-3-32-19(30)16-10-28(17-14(22)8-13(31-2)9-15(17)23)21(26-16)27-18(29)11-4-6-12(7-5-11)33-20(24)25/h4-10,20H,3H2,1-2H3,(H,26,27,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530516
(WO2022076764, Example 45)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNCC1 Show InChI InChI=1S/C23H23F2N5O4/c1-33-17-8-4-16(5-9-17)30-14-19(21(32)29-12-10-26-11-13-29)27-23(30)28-20(31)15-2-6-18(7-3-15)34-22(24)25/h2-9,14,22,26H,10-13H2,1H3,(H,27,28,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530519
(WO2022076764, Example 48)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1ccncc1 Show InChI InChI=1S/C25H19F4N5O4/c1-37-17-10-18(26)21(19(27)11-17)34-13-20(23(36)31-12-14-6-8-30-9-7-14)32-25(34)33-22(35)15-2-4-16(5-3-15)38-24(28)29/h2-11,13,24H,12H2,1H3,(H,31,36)(H,32,33,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530525
(WO2022076764, Example 54)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCOCC1 Show InChI InChI=1S/C23H20F4N4O5/c1-34-15-10-16(24)19(17(25)11-15)31-12-18(21(33)30-6-8-35-9-7-30)28-23(31)29-20(32)13-2-4-14(5-3-13)36-22(26)27/h2-5,10-12,22H,6-9H2,1H3,(H,28,29,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530527
(WO2022076764, Example 56)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cnc(C)cn1 Show InChI InChI=1S/C25H20F4N6O4/c1-13-9-31-15(10-30-13)11-32-23(37)20-12-35(21-18(26)7-17(38-2)8-19(21)27)25(33-20)34-22(36)14-3-5-16(6-4-14)39-24(28)29/h3-10,12,24H,11H2,1-2H3,(H,32,37)(H,33,34,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 89 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530531
(WO2022076764, Example 60)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCCO Show InChI InChI=1S/C22H20F4N4O5/c1-34-14-9-15(23)18(16(24)10-14)30-11-17(20(33)27-7-2-8-31)28-22(30)29-19(32)12-3-5-13(6-4-12)35-21(25)26/h3-6,9-11,21,31H,2,7-8H2,1H3,(H,27,33)(H,28,29,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530537
(4-[l-(2,6-Difluoro-4-methoxyphenyl)-2-[4-(difluoro...)Show SMILES CCNC(=O)N1CCC(CC1)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C26H27F4N5O4/c1-3-31-26(37)34-10-8-15(9-11-34)21-14-35(22-19(27)12-18(38-2)13-20(22)28)25(32-21)33-23(36)16-4-6-17(7-5-16)39-24(29)30/h4-7,12-15,24H,3,8-11H2,1-2H3,(H,31,37)(H,32,33,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 540 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530544
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((5-methyl-l...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2nnc(C)o2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C22H17F4N5O4/c1-11-29-30-18(34-11)7-13-10-31(19-16(23)8-15(33-2)9-17(19)24)22(27-13)28-20(32)12-3-5-14(6-4-12)35-21(25)26/h3-6,8-10,21H,7H2,1-2H3,(H,27,28,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530549
(WO2022076764, Example 78)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2ccccn2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C24H18F4N4O3/c1-34-18-11-19(25)21(20(26)12-18)32-13-16(10-15-4-2-3-9-29-15)30-24(32)31-22(33)14-5-7-17(8-6-14)35-23(27)28/h2-9,11-13,23H,10H2,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 870 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530472
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-phenyl-1H-im...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C24H17F4N3O3/c1-33-17-11-18(25)21(19(26)12-17)31-13-20(14-5-3-2-4-6-14)29-24(31)30-22(32)15-7-9-16(10-8-15)34-23(27)28/h2-13,23H,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530474
(WO2022076764, Example 3)Show SMILES COc1cccc(c1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H19F4N3O4/c1-34-17-5-3-4-15(10-17)21-13-32(22-19(26)11-18(35-2)12-20(22)27)25(30-21)31-23(33)14-6-8-16(9-7-14)36-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530478
(WO2022076764, Example 7)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H17F6N3O4/c1-36-17-10-18(26)21(19(27)11-17)34-12-20(13-2-6-15(7-3-13)37-23(28)29)32-25(34)33-22(35)14-4-8-16(9-5-14)38-24(30)31/h2-12,23-24H,1H3,(H,32,33,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530481
(WO2022076764, Example 10)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(F)c1 Show InChI InChI=1S/C24H16F5N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(14-3-2-4-15(25)9-14)30-24(32)31-22(33)13-5-7-16(8-6-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530485
(WO2022076764, Example 14)Show SMILES COc1ccc(cc1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H19F4N3O4/c1-34-16-7-3-14(4-8-16)21-13-32(22-19(26)11-18(35-2)12-20(22)27)25(30-21)31-23(33)15-5-9-17(10-6-15)36-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 39 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530488
(WO2022076764, Example 17)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(c1)C#N Show InChI InChI=1S/C25H16F4N4O3/c1-35-18-10-19(26)22(20(27)11-18)33-13-21(16-4-2-3-14(9-16)12-30)31-25(33)32-23(34)15-5-7-17(8-6-15)36-24(28)29/h2-11,13,24H,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 46 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530500
(WO2022076764, Example 29)Show SMILES CCOC(=O)c1cc(on1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1ccc(OC)cc1 Show InChI InChI=1S/C24H20F2N4O6/c1-3-34-22(32)18-12-20(36-29-18)19-13-30(15-6-10-16(33-2)11-7-15)24(27-19)28-21(31)14-4-8-17(9-5-14)35-23(25)26/h4-13,23H,3H2,1-2H3,(H,27,28,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530512
(WO2022076764, Example 41)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCOCC1 Show InChI InChI=1S/C23H21F4N3O4/c1-32-16-10-17(24)20(18(25)11-16)30-12-19(13-6-8-33-9-7-13)28-23(30)29-21(31)14-2-4-15(5-3-14)34-22(26)27/h2-5,10-13,22H,6-9H2,1H3,(H,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 230 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530515
(1-(2,6-Difluoro-4-methoxyphenyl)-2-[4-(difluoromet...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cc[nH]n1 Show InChI InChI=1S/C23H18F4N6O4/c1-36-15-8-16(24)19(17(25)9-15)33-11-18(21(35)28-10-13-6-7-29-32-13)30-23(33)31-20(34)12-2-4-14(5-3-12)37-22(26)27/h2-9,11,22H,10H2,1H3,(H,28,35)(H,29,32)(H,30,31,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530521
(WO2022076764, Example 50)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC[C@H]1CO Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-9-17(25)20(18(26)10-16)32-11-19(22(35)31-8-2-3-14(31)12-33)29-24(32)30-21(34)13-4-6-15(7-5-13)37-23(27)28/h4-7,9-11,14,23,33H,2-3,8,12H2,1H3,(H,29,30,34)/t14-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 77 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530531
(WO2022076764, Example 60)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCCO Show InChI InChI=1S/C22H20F4N4O5/c1-34-14-9-15(23)18(16(24)10-14)30-11-17(20(33)27-7-2-8-31)28-22(30)29-19(32)12-3-5-13(6-4-12)35-21(25)26/h3-6,9-11,21,31H,2,7-8H2,1H3,(H,27,33)(H,28,29,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 56 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530532
(WO2022076764, Example 61)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNCC1 Show InChI InChI=1S/C23H21F4N5O4/c1-35-15-10-16(24)19(17(25)11-15)32-12-18(21(34)31-8-6-28-7-9-31)29-23(32)30-20(33)13-2-4-14(5-3-13)36-22(26)27/h2-5,10-12,22,28H,6-9H2,1H3,(H,29,30,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530534
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-(piperidin-4...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCNCC1 Show InChI InChI=1S/C23H22F4N4O3/c1-33-16-10-17(24)20(18(25)11-16)31-12-19(13-6-8-28-9-7-13)29-23(31)30-21(32)14-2-4-15(5-3-14)34-22(26)27/h2-5,10-13,22,28H,6-9H2,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 710 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530536
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-[l-(ethanesu...)Show SMILES CCS(=O)(=O)N1CCC(CC1)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H26F4N4O5S/c1-3-39(35,36)32-10-8-15(9-11-32)21-14-33(22-19(26)12-18(37-2)13-20(22)27)25(30-21)31-23(34)16-4-6-17(7-5-16)38-24(28)29/h4-7,12-15,24H,3,8-11H2,1-2H3,(H,30,31,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 81 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530539
(WO2022076764, Example 68)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCN(CC1)C(=O)CCO Show InChI InChI=1S/C26H26F4N4O5/c1-38-18-12-19(27)23(20(28)13-18)34-14-21(15-6-9-33(10-7-15)22(36)8-11-35)31-26(34)32-24(37)16-2-4-17(5-3-16)39-25(29)30/h2-5,12-15,25,35H,6-11H2,1H3,(H,31,32,37) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 45 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530541
(N-(1-(2,6-Difluoro-4-methoxyphenyl)-4-isopropyl-1H...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(C)C Show InChI InChI=1S/C21H19F4N3O3/c1-11(2)17-10-28(18-15(22)8-14(30-3)9-16(18)23)21(26-17)27-19(29)12-4-6-13(7-5-12)31-20(24)25/h4-11,20H,1-3H3,(H,26,27,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530543
(WO2022076764, Example 72)Show SMILES CCOC(=O)Cc1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C22H19F4N3O5/c1-3-33-18(30)8-13-11-29(19-16(23)9-15(32-2)10-17(19)24)22(27-13)28-20(31)12-4-6-14(7-5-12)34-21(25)26/h4-7,9-11,21H,3,8H2,1-2H3,(H,27,28,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530543
(WO2022076764, Example 72)Show SMILES CCOC(=O)Cc1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C22H19F4N3O5/c1-3-33-18(30)8-13-11-29(19-16(23)9-15(32-2)10-17(19)24)22(27-13)28-20(31)12-4-6-14(7-5-12)34-21(25)26/h4-7,9-11,21H,3,8H2,1-2H3,(H,27,28,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 470 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530544
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((5-methyl-l...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2nnc(C)o2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C22H17F4N5O4/c1-11-29-30-18(34-11)7-13-10-31(19-16(23)8-15(33-2)9-17(19)24)22(27-13)28-20(32)12-3-5-14(6-4-12)35-21(25)26/h3-6,8-10,21H,7H2,1-2H3,(H,27,28,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530545
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-hydroxycy...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC(O)C2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C23H21F4N3O4/c1-33-17-9-18(24)20(19(25)10-17)30-11-14(6-12-7-15(31)8-12)28-23(30)29-21(32)13-2-4-16(5-3-13)34-22(26)27/h2-5,9-12,15,22,31H,6-8H2,1H3,(H,28,29,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530553
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-((2,2,2-t...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC(C2)NCC(F)(F)F)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H23F7N4O3/c1-38-18-9-19(26)21(20(27)10-18)36-11-16(8-13-6-15(7-13)33-12-25(30,31)32)34-24(36)35-22(37)14-2-4-17(5-3-14)39-23(28)29/h2-5,9-11,13,15,23,33H,6-8,12H2,1H3,(H,34,35,37) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 85 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530474
(WO2022076764, Example 3)Show SMILES COc1cccc(c1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H19F4N3O4/c1-34-17-5-3-4-15(10-17)21-13-32(22-19(26)11-18(35-2)12-20(22)27)25(30-21)31-23(33)14-6-8-16(9-7-14)36-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 88 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530476
(WO2022076764, Example 5)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)c(C)c1 Show InChI InChI=1S/C25H18ClF4N3O3/c1-13-9-15(5-8-18(13)26)21-12-33(22-19(27)10-17(35-2)11-20(22)28)25(31-21)32-23(34)14-3-6-16(7-4-14)36-24(29)30/h3-12,24H,1-2H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 47 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530479
(WO2022076764, Example 8)Show SMILES COc1cc(F)c(c(F)c1)-n1c(C)c(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C25H19F4N3O3/c1-14-21(15-6-4-3-5-7-15)30-25(32(14)22-19(26)12-18(34-2)13-20(22)27)31-23(33)16-8-10-17(11-9-16)35-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 230 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530490
(WO2022076764, Example 19)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2OCCc2c1 Show InChI InChI=1S/C26H21F2N3O4/c1-33-20-9-5-19(6-10-20)31-15-22(17-4-11-23-18(14-17)12-13-34-23)29-26(31)30-24(32)16-2-7-21(8-3-16)35-25(27)28/h2-11,14-15,25H,12-13H2,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 93 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530491
(WO2022076764, Example 20)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccnc(Cl)c1 Show InChI InChI=1S/C23H17ClF2N4O3/c1-32-17-8-4-16(5-9-17)30-13-19(15-10-11-27-20(24)12-15)28-23(30)29-21(31)14-2-6-18(7-3-14)33-22(25)26/h2-13,22H,1H3,(H,28,29,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530492
(WO2022076764, Example 21)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)cc1F Show InChI InChI=1S/C24H17F4N3O3/c1-33-17-9-5-16(6-10-17)31-13-21(19-11-4-15(25)12-20(19)26)29-24(31)30-22(32)14-2-7-18(8-3-14)34-23(27)28/h2-13,23H,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530494
(WO2022076764, Example 23)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2ccccc2s1 Show InChI InChI=1S/C25H18F2N4O3S/c1-33-17-12-8-16(9-13-17)31-14-20(23-28-19-4-2-3-5-21(19)35-23)29-25(31)30-22(32)15-6-10-18(11-7-15)34-24(26)27/h2-14,24H,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 28 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530494
(WO2022076764, Example 23)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2ccccc2s1 Show InChI InChI=1S/C25H18F2N4O3S/c1-33-17-12-8-16(9-13-17)31-14-20(23-28-19-4-2-3-5-21(19)35-23)29-25(31)30-22(32)15-6-10-18(11-7-15)34-24(26)27/h2-14,24H,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 44 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530501
(WO2022076764, Example 30)Show SMILES CCOC(=O)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1ccc(OC)cc1 Show InChI InChI=1S/C21H19F2N3O5/c1-3-30-19(28)17-12-26(14-6-10-15(29-2)11-7-14)21(24-17)25-18(27)13-4-8-16(9-5-13)31-20(22)23/h4-12,20H,3H2,1-2H3,(H,24,25,27) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530503
(WO2022076764, Example 32)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(C)(C)C Show InChI InChI=1S/C22H23F2N3O3/c1-22(2,3)18-13-27(15-7-11-16(29-4)12-8-15)21(25-18)26-19(28)14-5-9-17(10-6-14)30-20(23)24/h5-13,20H,1-4H3,(H,25,26,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530504
(WO2022076764, Example 33)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1F Show InChI InChI=1S/C24H16F5N3O3/c1-34-15-10-18(26)21(19(27)11-15)32-12-20(16-4-2-3-5-17(16)25)30-24(32)31-22(33)13-6-8-14(9-7-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 940 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530507
(WO2022076764, Example 36)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)c(F)c1 Show InChI InChI=1S/C24H15F6N3O3/c1-35-15-9-18(27)21(19(28)10-15)33-11-20(13-4-7-16(25)17(26)8-13)31-24(33)32-22(34)12-2-5-14(6-3-12)36-23(29)30/h2-11,23H,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530509
(WO2022076764, Example 38)Show SMILES CCOC(=O)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C21H17F4N3O5/c1-3-32-19(30)16-10-28(17-14(22)8-13(31-2)9-15(17)23)21(26-16)27-18(29)11-4-6-12(7-5-11)33-20(24)25/h4-10,20H,3H2,1-2H3,(H,26,27,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 620 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530511
(WO2022076764, Example 40)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nccs1 Show InChI InChI=1S/C21H14F4N4O3S/c1-31-13-8-14(22)17(15(23)9-13)29-10-16(19-26-6-7-33-19)27-21(29)28-18(30)11-2-4-12(5-3-11)32-20(24)25/h2-10,20H,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530519
(WO2022076764, Example 48)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1ccncc1 Show InChI InChI=1S/C25H19F4N5O4/c1-37-17-10-18(26)21(19(27)11-17)34-13-20(23(36)31-12-14-6-8-30-9-7-14)32-25(34)33-22(35)15-2-4-16(5-3-15)38-24(28)29/h2-11,13,24H,12H2,1H3,(H,31,36)(H,32,33,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530520
(WO2022076764, Example 49)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCC1CCC(O)CC1 Show InChI InChI=1S/C26H26F4N4O5/c1-38-18-10-19(27)22(20(28)11-18)34-13-21(24(37)31-12-14-2-6-16(35)7-3-14)32-26(34)33-23(36)15-4-8-17(9-5-15)39-25(29)30/h4-5,8-11,13-14,16,25,35H,2-3,6-7,12H2,1H3,(H,31,37)(H,32,33,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530522
(WO2022076764, Example 51)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCCC(O)C1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-9-17(25)20(18(26)10-16)32-12-19(22(35)31-8-2-3-14(33)11-31)29-24(32)30-21(34)13-4-6-15(7-5-13)37-23(27)28/h4-7,9-10,12,14,23,33H,2-3,8,11H2,1H3,(H,29,30,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 83 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530528
(WO2022076764, Example 57)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CC[C@H](O)C1 Show InChI InChI=1S/C23H20F4N4O5/c1-35-15-8-16(24)19(17(25)9-15)31-11-18(21(34)30-7-6-13(32)10-30)28-23(31)29-20(33)12-2-4-14(5-3-12)36-22(26)27/h2-5,8-9,11,13,22,32H,6-7,10H2,1H3,(H,28,29,33)/t13-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530533
(WO2022076764, Example 62)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)Nc1cn[nH]c1 Show InChI InChI=1S/C22H16F4N6O4/c1-35-14-6-15(23)18(16(24)7-14)32-10-17(20(34)29-12-8-27-28-9-12)30-22(32)31-19(33)11-2-4-13(5-3-11)36-21(25)26/h2-10,21H,1H3,(H,27,28)(H,29,34)(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530533
(WO2022076764, Example 62)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)Nc1cn[nH]c1 Show InChI InChI=1S/C22H16F4N6O4/c1-35-14-6-15(23)18(16(24)7-14)32-10-17(20(34)29-12-8-27-28-9-12)30-22(32)31-19(33)11-2-4-13(5-3-11)36-21(25)26/h2-10,21H,1H3,(H,27,28)(H,29,34)(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 830 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530535
(4-(Difluoromethoxy)-N-[1-(4-methoxyphenyl)-4-(pipe...)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCCNC1 Show InChI InChI=1S/C23H24F2N4O3/c1-31-18-10-6-17(7-11-18)29-14-20(16-3-2-12-26-13-16)27-23(29)28-21(30)15-4-8-19(9-5-15)32-22(24)25/h4-11,14,16,22,26H,2-3,12-13H2,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530539
(WO2022076764, Example 68)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCN(CC1)C(=O)CCO Show InChI InChI=1S/C26H26F4N4O5/c1-38-18-12-19(27)23(20(28)13-18)34-14-21(15-6-9-33(10-7-15)22(36)8-11-35)31-26(34)32-24(37)16-2-4-17(5-3-16)39-25(29)30/h2-5,12-15,25,35H,6-11H2,1H3,(H,31,32,37) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530540
(WO2022076764, Example 69)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(CO)CC1 Show InChI InChI=1S/C25H24F4N4O5/c1-37-17-10-18(26)21(19(27)11-17)33-12-20(23(36)32-8-6-14(13-34)7-9-32)30-25(33)31-22(35)15-2-4-16(5-3-15)38-24(28)29/h2-5,10-12,14,24,34H,6-9,13H2,1H3,(H,30,31,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 2.99E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530542
(WO2022076764, Example 71)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2ccccc2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H19F4N3O3/c1-34-19-12-20(26)22(21(27)13-19)32-14-17(11-15-5-3-2-4-6-15)30-25(32)31-23(33)16-7-9-18(10-8-16)35-24(28)29/h2-10,12-14,24H,11H2,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530546
(N-( 1-(2,6-Difluoro-4-methoxyphenyl)-4-(2-azaspiro...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC3(CNC3)C2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H24F4N4O3/c1-35-18-7-19(26)21(20(27)8-18)33-11-16(6-14-9-25(10-14)12-30-13-25)31-24(33)32-22(34)15-2-4-17(5-3-15)36-23(28)29/h2-5,7-8,11,14,23,30H,6,9-10,12-13H2,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530547
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(4-hydroxycy...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCC(O)CC1 Show InChI InChI=1S/C24H23F4N3O4/c1-34-17-10-18(25)21(19(26)11-17)31-12-20(13-2-6-15(32)7-3-13)29-24(31)30-22(33)14-4-8-16(9-5-14)35-23(27)28/h4-5,8-13,15,23,32H,2-3,6-7H2,1H3,(H,29,30,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530548
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((6-fluoro-1...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2ncc(N)cc2[nH]1 Show InChI InChI=1S/C24H17F4N7O3/c1-37-14-7-15(25)19(16(26)8-14)35-10-18(21-31-17-6-12(29)9-30-20(17)33-21)32-24(35)34-22(36)11-2-4-13(5-3-11)38-23(27)28/h2-10,23H,29H2,1H3,(H,30,31,33)(H,32,34,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530473
(WO2022076764, Example 2)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C24H19F2N3O3/c1-31-19-13-9-18(10-14-19)29-15-21(16-5-3-2-4-6-16)27-24(29)28-22(30)17-7-11-20(12-8-17)32-23(25)26/h2-15,23H,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530473
(WO2022076764, Example 2)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C24H19F2N3O3/c1-31-19-13-9-18(10-14-19)29-15-21(16-5-3-2-4-6-16)27-24(29)28-22(30)17-7-11-20(12-8-17)32-23(25)26/h2-15,23H,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 38 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530476
(WO2022076764, Example 5)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)c(C)c1 Show InChI InChI=1S/C25H18ClF4N3O3/c1-13-9-15(5-8-18(13)26)21-12-33(22-19(27)10-17(35-2)11-20(22)28)25(31-21)32-23(34)14-3-6-16(7-4-14)36-24(29)30/h3-12,24H,1-2H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530481
(WO2022076764, Example 10)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1cccc(F)c1 Show InChI InChI=1S/C24H16F5N3O3/c1-34-17-10-18(26)21(19(27)11-17)32-12-20(14-3-2-4-15(25)9-14)30-24(32)31-22(33)13-5-7-16(8-6-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530486
(WO2022076764, Example 15)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(C)cc1 Show InChI InChI=1S/C25H19F4N3O3/c1-14-3-5-15(6-4-14)21-13-32(22-19(26)11-18(34-2)12-20(22)27)25(30-21)31-23(33)16-7-9-17(10-8-16)35-24(28)29/h3-13,24H,1-2H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530498
(WO2022076764, Example 27)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCCCC1 Show InChI InChI=1S/C24H25F2N3O3/c1-31-19-13-9-18(10-14-19)29-15-21(16-5-3-2-4-6-16)27-24(29)28-22(30)17-7-11-20(12-8-17)32-23(25)26/h7-16,23H,2-6H2,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 660 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530499
(WO2022076764, Example 28)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccn1 Show InChI InChI=1S/C23H18F2N4O3/c1-31-17-11-7-16(8-12-17)29-14-20(19-4-2-3-13-26-19)27-23(29)28-21(30)15-5-9-18(10-6-15)32-22(24)25/h2-14,22H,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 700 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530501
(WO2022076764, Example 30)Show SMILES CCOC(=O)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1ccc(OC)cc1 Show InChI InChI=1S/C21H19F2N3O5/c1-3-30-19(28)17-12-26(14-6-10-15(29-2)11-7-14)21(24-17)25-18(27)13-4-8-16(9-5-13)31-20(22)23/h4-12,20H,3H2,1-2H3,(H,24,25,27) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530503
(WO2022076764, Example 32)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(C)(C)C Show InChI InChI=1S/C22H23F2N3O3/c1-22(2,3)18-13-27(15-7-11-16(29-4)12-8-15)21(25-18)26-19(28)14-5-9-17(10-6-14)30-20(23)24/h5-13,20H,1-4H3,(H,25,26,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530505
(WO2022076764, Example 34)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccnc(Cl)c1 Show InChI InChI=1S/C23H15ClF4N4O3/c1-34-15-9-16(25)20(17(26)10-15)32-11-18(13-6-7-29-19(24)8-13)30-23(32)31-21(33)12-2-4-14(5-3-12)35-22(27)28/h2-11,22H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530508
(WO2022076764, Example 37)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC1 Show InChI InChI=1S/C21H17F4N3O3/c1-30-14-8-15(22)18(16(23)9-14)28-10-17(11-2-3-11)26-21(28)27-19(29)12-4-6-13(7-5-12)31-20(24)25/h4-11,20H,2-3H2,1H3,(H,26,27,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 800 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530512
(WO2022076764, Example 41)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCOCC1 Show InChI InChI=1S/C23H21F4N3O4/c1-32-16-10-17(24)20(18(25)11-16)30-12-19(13-6-8-33-9-7-13)28-23(30)29-21(31)14-2-4-15(5-3-14)34-22(26)27/h2-5,10-13,22H,6-9H2,1H3,(H,28,29,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530517
(WO2022076764, Example 46)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCCO Show InChI InChI=1S/C22H22F2N4O5/c1-32-16-9-5-15(6-10-16)28-13-18(20(31)25-11-2-12-29)26-22(28)27-19(30)14-3-7-17(8-4-14)33-21(23)24/h3-10,13,21,29H,2,11-12H2,1H3,(H,25,31)(H,26,27,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 27 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530517
(WO2022076764, Example 46)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCCO Show InChI InChI=1S/C22H22F2N4O5/c1-32-16-9-5-15(6-10-16)28-13-18(20(31)25-11-2-12-29)26-22(28)27-19(30)14-3-7-17(8-4-14)33-21(23)24/h3-10,13,21,29H,2,11-12H2,1H3,(H,25,31)(H,26,27,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530528
(WO2022076764, Example 57)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CC[C@H](O)C1 Show InChI InChI=1S/C23H20F4N4O5/c1-35-15-8-16(24)19(17(25)9-15)31-11-18(21(34)30-7-6-13(32)10-30)28-23(31)29-20(33)12-2-4-14(5-3-12)36-22(26)27/h2-5,8-9,11,13,22,32H,6-7,10H2,1H3,(H,28,29,33)/t13-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530538
(A-{4-[1-(3-Carbamoylpropanoyl)piperidin-4-yl]-1-(2...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCN(CC1)C(=O)CCC(N)=O Show InChI InChI=1S/C27H27F4N5O5/c1-40-18-12-19(28)24(20(29)13-18)36-14-21(15-8-10-35(11-9-15)23(38)7-6-22(32)37)33-27(36)34-25(39)16-2-4-17(5-3-16)41-26(30)31/h2-5,12-15,26H,6-11H2,1H3,(H2,32,37)(H,33,34,39) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 83 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530548
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((6-fluoro-1...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2ncc(N)cc2[nH]1 Show InChI InChI=1S/C24H17F4N7O3/c1-37-14-7-15(25)19(16(26)8-14)35-10-18(21-31-17-6-12(29)9-30-20(17)33-21)32-24(35)34-22(36)11-2-4-13(5-3-11)38-23(27)28/h2-10,23H,29H2,1H3,(H,30,31,33)(H,32,34,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530552
(WO2022076764, Example 81)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC(N)C1 Show InChI InChI=1S/C22H20F4N4O3/c1-32-15-8-16(23)19(17(24)9-15)30-10-18(12-6-13(27)7-12)28-22(30)29-20(31)11-2-4-14(5-3-11)33-21(25)26/h2-5,8-10,12-13,21H,6-7,27H2,1H3,(H,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530553
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-((2,2,2-t...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC(C2)NCC(F)(F)F)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H23F7N4O3/c1-38-18-9-19(26)21(20(27)10-18)36-11-16(8-13-6-15(7-13)33-12-25(30,31)32)34-24(36)35-22(37)14-2-4-17(5-3-14)39-23(28)29/h2-5,9-11,13,15,23,33H,6-8,12H2,1H3,(H,34,35,37) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530472
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-phenyl-1H-im...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1 Show InChI InChI=1S/C24H17F4N3O3/c1-33-17-11-18(25)21(19(26)12-17)31-13-20(14-5-3-2-4-6-14)29-24(31)30-22(32)15-7-9-16(10-8-15)34-23(27)28/h2-13,23H,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530477
(WO2022076764, Example 6)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(cc1)C(F)(F)F Show InChI InChI=1S/C25H16F7N3O3/c1-37-17-10-18(26)21(19(27)11-17)35-12-20(13-2-6-15(7-3-13)25(30,31)32)33-24(35)34-22(36)14-4-8-16(9-5-14)38-23(28)29/h2-12,23H,1H3,(H,33,34,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530480
(WO2022076764, Example 9)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2ccccc2c1 Show InChI InChI=1S/C28H19F4N3O3/c1-37-21-13-22(29)25(23(30)14-21)35-15-24(19-7-6-16-4-2-3-5-18(16)12-19)33-28(35)34-26(36)17-8-10-20(11-9-17)38-27(31)32/h2-15,27H,1H3,(H,33,34,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 460 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530502
(WO2022076764, Example 31)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C12CC3CC(CC(C3)C1)C2 Show InChI InChI=1S/C28H29F2N3O3/c1-35-22-8-4-21(5-9-22)33-16-24(28-13-17-10-18(14-28)12-19(11-17)15-28)31-27(33)32-25(34)20-2-6-23(7-3-20)36-26(29)30/h2-9,16-19,26H,10-15H2,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530502
(WO2022076764, Example 31)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C12CC3CC(CC(C3)C1)C2 Show InChI InChI=1S/C28H29F2N3O3/c1-35-22-8-4-21(5-9-22)33-16-24(28-13-17-10-18(14-28)12-19(11-17)15-28)31-27(33)32-25(34)20-2-6-23(7-3-20)36-26(29)30/h2-9,16-19,26H,10-15H2,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530508
(WO2022076764, Example 37)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC1 Show InChI InChI=1S/C21H17F4N3O3/c1-30-14-8-15(22)18(16(23)9-14)28-10-17(11-2-3-11)26-21(28)27-19(29)12-4-6-13(7-5-12)31-20(24)25/h4-11,20H,2-3H2,1H3,(H,26,27,29) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530514
(WO2022076764, Example 43)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(F)(F)F Show InChI InChI=1S/C19H12F7N3O3/c1-31-11-6-12(20)15(13(21)7-11)29-8-14(19(24,25)26)27-18(29)28-16(30)9-2-4-10(5-3-9)32-17(22)23/h2-8,17H,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530514
(WO2022076764, Example 43)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(F)(F)F Show InChI InChI=1S/C19H12F7N3O3/c1-31-11-6-12(20)15(13(21)7-11)29-8-14(19(24,25)26)27-18(29)28-16(30)9-2-4-10(5-3-9)32-17(22)23/h2-8,17H,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 40 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530515
(1-(2,6-Difluoro-4-methoxyphenyl)-2-[4-(difluoromet...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cc[nH]n1 Show InChI InChI=1S/C23H18F4N6O4/c1-36-15-8-16(24)19(17(25)9-15)33-11-18(21(35)28-10-13-6-7-29-32-13)30-23(33)31-20(34)12-2-4-14(5-3-12)37-22(26)27/h2-9,11,22H,10H2,1H3,(H,28,35)(H,29,32)(H,30,31,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 370 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530523
(WO2022076764, Example 52)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(O)CC1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-10-17(25)20(18(26)11-16)32-12-19(22(35)31-8-6-14(33)7-9-31)29-24(32)30-21(34)13-2-4-15(5-3-13)37-23(27)28/h2-5,10-12,14,23,33H,6-9H2,1H3,(H,29,30,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530525
(WO2022076764, Example 54)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCOCC1 Show InChI InChI=1S/C23H20F4N4O5/c1-34-15-10-16(24)19(17(25)11-15)31-12-18(21(33)30-6-8-35-9-7-30)28-23(31)29-20(32)13-2-4-14(5-3-13)36-22(26)27/h2-5,10-12,22H,6-9H2,1H3,(H,28,29,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530530
(WO2022076764, Example 59)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(CO)C1 Show InChI InChI=1S/C24H22F4N4O5/c1-36-16-8-17(25)20(18(26)9-16)32-11-19(22(35)31-7-6-13(10-31)12-33)29-24(32)30-21(34)14-2-4-15(5-3-14)37-23(27)28/h2-5,8-9,11,13,23,33H,6-7,10,12H2,1H3,(H,29,30,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530541
(N-(1-(2,6-Difluoro-4-methoxyphenyl)-4-isopropyl-1H...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(C)C Show InChI InChI=1S/C21H19F4N3O3/c1-11(2)17-10-28(18-15(22)8-14(30-3)9-16(18)23)21(26-17)27-19(29)12-4-6-13(7-5-12)31-20(24)25/h4-11,20H,1-3H3,(H,26,27,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 970 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530542
(WO2022076764, Example 71)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2ccccc2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H19F4N3O3/c1-34-19-12-20(26)22(21(27)13-19)32-14-17(11-15-5-3-2-4-6-15)30-25(32)31-23(33)16-7-9-18(10-8-16)35-24(28)29/h2-10,12-14,24H,11H2,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 46 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530545
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-hydroxycy...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC(O)C2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C23H21F4N3O4/c1-33-17-9-18(24)20(19(25)10-17)30-11-14(6-12-7-15(31)8-12)28-23(30)29-21(32)13-2-4-16(5-3-13)34-22(26)27/h2-5,9-12,15,22,31H,6-8H2,1H3,(H,28,29,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 250 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530546
(N-( 1-(2,6-Difluoro-4-methoxyphenyl)-4-(2-azaspiro...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC2CC3(CNC3)C2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C25H24F4N4O3/c1-35-18-7-19(26)21(20(27)8-18)33-11-16(6-14-9-25(10-14)12-30-13-25)31-24(33)32-22(34)15-2-4-17(5-3-15)36-23(28)29/h2-5,7-8,11,14,23,30H,6,9-10,12-13H2,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530550
(WO2022076764, Example 79)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CNC1 Show InChI InChI=1S/C21H18F4N4O3/c1-31-14-6-15(22)18(16(23)7-14)29-10-17(12-8-26-9-12)27-21(29)28-19(30)11-2-4-13(5-3-11)32-20(24)25/h2-7,10,12,20,26H,8-9H2,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 81 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530551
(WO2022076764, Example 80)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccn[nH]1 Show InChI InChI=1S/C21H15F4N5O3/c1-32-13-8-14(22)18(15(23)9-13)30-10-17(16-6-7-26-29-16)27-21(30)28-19(31)11-2-4-12(5-3-11)33-20(24)25/h2-10,20H,1H3,(H,26,29)(H,27,28,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530554
(N-[l-(2,6-Ddifluoro-4-methoxyphenyl)-4-(3-methanes...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC(C1)NS(C)(=O)=O Show InChI InChI=1S/C23H22F4N4O5S/c1-35-16-9-17(24)20(18(25)10-16)31-11-19(13-7-14(8-13)30-37(2,33)34)28-23(31)29-21(32)12-3-5-15(6-4-12)36-22(26)27/h3-6,9-11,13-14,22,30H,7-8H2,1-2H3,(H,28,29,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530484
(WO2022076764, Example 13)Show SMILES COc1cc(F)c(c(F)c1)-n1c(C)c(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C25H18ClF4N3O3/c1-13-21(14-3-7-16(26)8-4-14)31-25(33(13)22-19(27)11-18(35-2)12-20(22)28)32-23(34)15-5-9-17(10-6-15)36-24(29)30/h3-12,24H,1-2H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 53 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530487
(WO2022076764, Example 16)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(cc1)C#N Show InChI InChI=1S/C25H16F4N4O3/c1-35-18-10-19(26)22(20(27)11-18)33-13-21(15-4-2-14(12-30)3-5-15)31-25(33)32-23(34)16-6-8-17(9-7-16)36-24(28)29/h2-11,13,24H,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 230 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530489
(WO2022076764, Example 18)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)c(Cl)c1 Show InChI InChI=1S/C24H15Cl2F4N3O3/c1-35-15-9-18(27)21(19(28)10-15)33-11-20(13-4-7-16(25)17(26)8-13)31-24(33)32-22(34)12-2-5-14(6-3-12)36-23(29)30/h2-11,23H,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 51 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530490
(WO2022076764, Example 19)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2OCCc2c1 Show InChI InChI=1S/C26H21F2N3O4/c1-33-20-9-5-19(6-10-20)31-15-22(17-4-11-23-18(14-17)12-13-34-23)29-26(31)30-24(32)16-2-7-21(8-3-16)35-25(27)28/h2-11,14-15,25H,12-13H2,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 28 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530495
(WO2022076764, Example 24)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nccs1 Show InChI InChI=1S/C21H16F2N4O3S/c1-29-15-8-4-14(5-9-15)27-12-17(19-24-10-11-31-19)25-21(27)26-18(28)13-2-6-16(7-3-13)30-20(22)23/h2-12,20H,1H3,(H,25,26,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530497
(WO2022076764, Example 26)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nc2cc(Cl)ccc2o1 Show InChI InChI=1S/C25H17ClF2N4O4/c1-34-17-9-5-16(6-10-17)32-13-20(23-29-19-12-15(26)4-11-21(19)36-23)30-25(32)31-22(33)14-2-7-18(8-3-14)35-24(27)28/h2-13,24H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530498
(WO2022076764, Example 27)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCCCC1 Show InChI InChI=1S/C24H25F2N3O3/c1-31-19-13-9-18(10-14-19)29-15-21(16-5-3-2-4-6-16)27-24(29)28-22(30)17-7-11-20(12-8-17)32-23(25)26/h7-16,23H,2-6H2,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530500
(WO2022076764, Example 29)Show SMILES CCOC(=O)c1cc(on1)-c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1ccc(OC)cc1 Show InChI InChI=1S/C24H20F2N4O6/c1-3-34-22(32)18-12-20(36-29-18)19-13-30(15-6-10-16(33-2)11-7-15)24(27-19)28-21(31)14-4-8-17(9-5-14)35-23(25)26/h4-13,23H,3H2,1-2H3,(H,27,28,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530504
(WO2022076764, Example 33)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccccc1F Show InChI InChI=1S/C24H16F5N3O3/c1-34-15-10-18(26)21(19(27)11-15)32-12-20(16-4-2-3-5-17(16)25)30-24(32)31-22(33)13-6-8-14(9-7-13)35-23(28)29/h2-12,23H,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 39 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530510
(WO2022076764, Example 39)Show SMILES CCc1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C20H17F4N3O3/c1-3-12-10-27(17-15(21)8-14(29-2)9-16(17)22)20(25-12)26-18(28)11-4-6-13(7-5-11)30-19(23)24/h4-10,19H,3H2,1-2H3,(H,25,26,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530518
(WO2022076764, Example 47)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cccnc1 Show InChI InChI=1S/C25H19F4N5O4/c1-37-17-9-18(26)21(19(27)10-17)34-13-20(23(36)31-12-14-3-2-8-30-11-14)32-25(34)33-22(35)15-4-6-16(7-5-15)38-24(28)29/h2-11,13,24H,12H2,1H3,(H,31,36)(H,32,33,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530520
(WO2022076764, Example 49)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCC1CCC(O)CC1 Show InChI InChI=1S/C26H26F4N4O5/c1-38-18-10-19(27)22(20(28)11-18)34-13-21(24(37)31-12-14-2-6-16(35)7-3-14)32-26(34)33-23(36)15-4-8-17(9-5-15)39-25(29)30/h4-5,8-11,13-14,16,25,35H,2-3,6-7,12H2,1H3,(H,31,37)(H,32,33,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530524
(WO2022076764, Example 53)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCO Show InChI InChI=1S/C21H18F4N4O5/c1-33-13-8-14(22)17(15(23)9-13)29-10-16(19(32)26-6-7-30)27-21(29)28-18(31)11-2-4-12(5-3-11)34-20(24)25/h2-5,8-10,20,30H,6-7H2,1H3,(H,26,32)(H,27,28,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| KEGG
UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530526
(WO2022076764, Example 55)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCN(C)CC1 Show InChI InChI=1S/C24H23F4N5O4/c1-31-7-9-32(10-8-31)22(35)19-13-33(20-17(25)11-16(36-2)12-18(20)26)24(29-19)30-21(34)14-3-5-15(6-4-14)37-23(27)28/h3-6,11-13,23H,7-10H2,1-2H3,(H,29,30,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530529
(WO2022076764, Example 58)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNC(=O)C1 Show InChI InChI=1S/C23H19F4N5O5/c1-36-14-8-15(24)19(16(25)9-14)32-10-17(21(35)31-7-6-28-18(33)11-31)29-23(32)30-20(34)12-2-4-13(5-3-12)37-22(26)27/h2-5,8-10,22H,6-7,11H2,1H3,(H,28,33)(H,29,30,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 3.40E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530534
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-(piperidin-4...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCNCC1 Show InChI InChI=1S/C23H22F4N4O3/c1-33-16-10-17(24)20(18(25)11-16)31-12-19(13-6-8-28-9-7-13)29-23(31)30-21(32)14-2-4-15(5-3-14)34-22(26)27/h2-5,10-13,22,28H,6-9H2,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530535
(4-(Difluoromethoxy)-N-[1-(4-methoxyphenyl)-4-(pipe...)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCCNC1 Show InChI InChI=1S/C23H24F2N4O3/c1-31-18-10-6-17(7-11-18)29-14-20(16-3-2-12-26-13-16)27-23(29)28-21(30)15-4-8-19(9-5-15)32-22(24)25/h4-11,14,16,22,26H,2-3,12-13H2,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530537
(4-[l-(2,6-Difluoro-4-methoxyphenyl)-2-[4-(difluoro...)Show SMILES CCNC(=O)N1CCC(CC1)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C26H27F4N5O4/c1-3-31-26(37)34-10-8-15(9-11-34)21-14-35(22-19(27)12-18(38-2)13-20(22)28)25(32-21)33-23(36)16-4-6-17(7-5-16)39-24(29)30/h4-7,12-15,24H,3,8-11H2,1-2H3,(H,31,37)(H,32,33,36) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 28 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530540
(WO2022076764, Example 69)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCC(CO)CC1 Show InChI InChI=1S/C25H24F4N4O5/c1-37-17-10-18(26)21(19(27)11-17)33-12-20(23(36)32-8-6-14(13-34)7-9-32)30-25(33)31-22(35)15-2-4-16(5-3-15)38-24(28)29/h2-5,10-12,14,24,34H,6-9,13H2,1H3,(H,30,31,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 86 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530547
(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(4-hydroxycy...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CCC(O)CC1 Show InChI InChI=1S/C24H23F4N3O4/c1-34-17-10-18(25)21(19(26)11-17)31-12-20(13-2-6-15(32)7-3-13)29-24(31)30-22(33)14-4-8-16(9-5-14)35-23(27)28/h4-5,8-13,15,23,32H,2-3,6-7H2,1H3,(H,29,30,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 240 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530550
(WO2022076764, Example 79)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CNC1 Show InChI InChI=1S/C21H18F4N4O3/c1-31-14-6-15(22)18(16(23)7-14)29-10-17(12-8-26-9-12)27-21(29)28-19(30)11-2-4-13(5-3-11)32-20(24)25/h2-7,10,12,20,26H,8-9H2,1H3,(H,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530551
(WO2022076764, Example 80)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccn[nH]1 Show InChI InChI=1S/C21H15F4N5O3/c1-32-13-8-14(22)18(15(23)9-13)30-10-17(16-6-7-26-29-16)27-21(30)28-19(31)11-2-4-12(5-3-11)33-20(24)25/h2-10,20H,1H3,(H,26,29)(H,27,28,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 59 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530552
(WO2022076764, Example 81)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC(N)C1 Show InChI InChI=1S/C22H20F4N4O3/c1-32-15-8-16(23)19(17(24)9-15)30-10-18(12-6-13(27)7-12)28-22(30)29-20(31)11-2-4-14(5-3-11)33-21(25)26/h2-5,8-10,12-13,21H,6-7,27H2,1H3,(H,28,29,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530554
(N-[l-(2,6-Ddifluoro-4-methoxyphenyl)-4-(3-methanes...)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C1CC(C1)NS(C)(=O)=O Show InChI InChI=1S/C23H22F4N4O5S/c1-35-16-9-17(24)20(18(25)10-16)31-11-19(13-7-14(8-13)30-37(2,33)34)28-23(31)29-21(32)12-3-5-15(6-4-12)36-22(26)27/h3-6,9-11,13-14,22,30H,7-8H2,1-2H3,(H,28,29,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530484
(WO2022076764, Example 13)Show SMILES COc1cc(F)c(c(F)c1)-n1c(C)c(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)cc1 Show InChI InChI=1S/C25H18ClF4N3O3/c1-13-21(14-3-7-16(26)8-4-14)31-25(33(13)22-19(27)11-18(35-2)12-20(22)28)32-23(34)15-5-9-17(10-6-15)36-24(29)30/h3-12,24H,1-2H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 550 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530487
(WO2022076764, Example 16)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(cc1)C#N Show InChI InChI=1S/C25H16F4N4O3/c1-35-18-10-19(26)22(20(27)11-18)33-13-21(15-4-2-14(12-30)3-5-15)31-25(33)32-23(34)16-6-8-17(9-7-16)36-24(28)29/h2-11,13,24H,1H3,(H,31,32,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 27 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530489
(WO2022076764, Example 18)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(Cl)c(Cl)c1 Show InChI InChI=1S/C24H15Cl2F4N3O3/c1-35-15-9-18(27)21(19(28)10-15)33-11-20(13-4-7-16(25)17(26)8-13)31-24(33)32-22(34)12-2-5-14(6-3-12)36-23(29)30/h2-11,23H,1H3,(H,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530491
(WO2022076764, Example 20)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccnc(Cl)c1 Show InChI InChI=1S/C23H17ClF2N4O3/c1-32-17-8-4-16(5-9-17)30-13-19(15-10-11-27-20(24)12-15)28-23(30)29-21(31)14-2-6-18(7-3-14)33-22(25)26/h2-13,22H,1H3,(H,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530492
(WO2022076764, Example 21)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc(F)cc1F Show InChI InChI=1S/C24H17F4N3O3/c1-33-17-9-5-16(6-10-17)31-13-21(19-11-4-15(25)12-20(19)26)29-24(31)30-22(32)14-2-7-18(8-3-14)34-23(27)28/h2-13,23H,1H3,(H,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 76 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530493
(WO2022076764, Example 22)Show SMILES COc1ccc(cc1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1ccc2sccc2c1 Show InChI InChI=1S/C26H19F2N3O3S/c1-33-20-9-5-19(6-10-20)31-15-22(17-4-11-23-18(14-17)12-13-35-23)29-26(31)30-24(32)16-2-7-21(8-3-16)34-25(27)28/h2-15,25H,1H3,(H,29,30,32) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 86 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530506
(WO2022076764, Example 35)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(CC(C)C)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C22H21F4N3O3/c1-12(2)8-14-11-29(19-17(23)9-16(31-3)10-18(19)24)22(27-14)28-20(30)13-4-6-15(7-5-13)32-21(25)26/h4-7,9-12,21H,8H2,1-3H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 99 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530510
(WO2022076764, Example 39)Show SMILES CCc1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C20H17F4N3O3/c1-3-12-10-27(17-15(21)8-14(29-2)9-16(17)22)20(25-12)26-18(28)11-4-6-13(7-5-11)30-19(23)24/h4-10,19H,3H2,1-2H3,(H,25,26,28) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 21 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530511
(WO2022076764, Example 40)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)-c1nccs1 Show InChI InChI=1S/C21H14F4N4O3S/c1-31-13-8-14(22)17(15(23)9-13)29-10-16(19-26-6-7-33-19)27-21(29)28-18(30)11-2-4-12(5-3-11)32-20(24)25/h2-10,20H,1H3,(H,27,28,30) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530513
(WO2022076764, Example 42)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(F)(F)C(F)(F)F Show InChI InChI=1S/C20H12F9N3O3/c1-34-11-6-12(21)15(13(22)7-11)32-8-14(19(25,26)20(27,28)29)30-18(32)31-16(33)9-2-4-10(5-3-9)35-17(23)24/h2-8,17H,1H3,(H,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 57 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530518
(WO2022076764, Example 47)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cccnc1 Show InChI InChI=1S/C25H19F4N5O4/c1-37-17-9-18(26)21(19(27)10-17)34-13-20(23(36)31-12-14-3-2-8-30-11-14)32-25(34)33-22(35)15-4-6-16(7-5-15)38-24(28)29/h2-11,13,24H,12H2,1H3,(H,31,36)(H,32,33,35) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 35 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530524
(WO2022076764, Example 53)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCCO Show InChI InChI=1S/C21H18F4N4O5/c1-33-13-8-14(22)17(15(23)9-13)29-10-16(19(32)26-6-7-30)27-21(29)28-18(31)11-2-4-12(5-3-11)34-20(24)25/h2-5,8-10,20,30H,6-7H2,1H3,(H,26,32)(H,27,28,31) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| KEGG
UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530527
(WO2022076764, Example 56)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)NCc1cnc(C)cn1 Show InChI InChI=1S/C25H20F4N6O4/c1-13-9-31-15(10-30-13)11-32-23(37)20-12-35(21-18(26)7-17(38-2)8-19(21)27)25(33-20)34-22(36)14-3-5-16(6-4-14)39-24(28)29/h3-10,12,24H,11H2,1-2H3,(H,32,37)(H,33,34,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530529
(WO2022076764, Example 58)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNC(=O)C1 Show InChI InChI=1S/C23H19F4N5O5/c1-36-14-8-15(24)19(16(25)9-14)32-10-17(21(35)31-7-6-28-18(33)11-31)29-23(32)30-20(34)12-2-4-13(5-3-12)37-22(26)27/h2-5,8-10,22H,6-7,11H2,1H3,(H,28,33)(H,29,30,34) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530532
(WO2022076764, Example 61)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(nc1NC(=O)c1ccc(OC(F)F)cc1)C(=O)N1CCNCC1 Show InChI InChI=1S/C23H21F4N5O4/c1-35-15-10-16(24)19(17(25)11-15)32-12-18(21(34)31-8-6-28-7-9-31)29-23(32)30-20(33)13-2-4-14(5-3-13)36-22(26)27/h2-5,10-12,22,28H,6-9H2,1H3,(H,29,30,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
N-formyl peptide receptor 2
(Homo sapiens (Human)) | BDBM530536
(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-[l-(ethanesu...)Show SMILES CCS(=O)(=O)N1CCC(CC1)c1cn(c(NC(=O)c2ccc(OC(F)F)cc2)n1)-c1c(F)cc(OC)cc1F Show InChI InChI=1S/C25H26F4N4O5S/c1-3-39(35,36)32-10-8-15(9-11-32)21-14-33(22-19(26)12-18(37-2)13-20(22)27)25(30-21)31-23(34)16-4-6-17(7-5-16)38-24(28)29/h4-7,12-15,24H,3,8-11H2,1-2H3,(H,30,31,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
fMet-Leu-Phe receptor
(Homo sapiens (Human)) | BDBM530549
(WO2022076764, Example 78)Show SMILES COc1cc(F)c(c(F)c1)-n1cc(Cc2ccccn2)nc1NC(=O)c1ccc(OC(F)F)cc1 Show InChI InChI=1S/C24H18F4N4O3/c1-34-18-11-19(25)21(20(26)12-18)32-13-16(10-15-4-2-3-9-29-15)30-24(32)31-22(33)14-5-7-17(8-6-14)35-23(27)28/h2-9,11-13,23H,10H2,1H3,(H,30,31,33) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
| UniChem
| WIPO WO2022076764
| n/a | n/a | n/a | n/a | 56 | n/a | n/a | n/a | n/a |
BRISTOL-MYERS SQUIBB COMPANY
WIPO
| |
WIPO WO2022076764 (2022)
|
More data for this
Ligand-Target Pair | |
Search and Browse
